• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Integra LifeSciences Holdings Corporation - Common Stock (NQ: IART )

    22.33 -0.37 (-1.63%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Integra LifeSciences Holdings Corporation - Common Stock

    < Previous 1 2 3 4 5 6 7 8 Next >
    INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Integra LifeSciences Holdings Corporation and Encourages Investors with Losses to Contact the Firm
    From The Schall Law Firm
    Via Business Wire
    IART INVESTOR NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages Integra LifeSciences Holdings Corporation Investors to Inquire About Securities Class Action Investigation – IART
    From Rosen Law Firm
    Via Business Wire
    Why Integra LifeSciences Stock Is Crashing Today
    Quality issues at one of Integra's facilities could be costly. 
    Via The Motley Fool
    Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Wall Street Stalls As Default Deadline Looms
    Wall Street is lower this afternoon as the default debate rages on. 
    Via Talk Markets
    Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
    Via Benzinga
    BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
    U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Analyst Ratings for Integra Lifesciences
    Via Benzinga
    Integra Lifesciences Earnings Perspective: Return On Capital Employed
    Via Benzinga
    Why Integra LifeSciences (IART) Stock Is Plunging Today
    Integra LifeSciences Holdings Corp (NASDAQ: IART) reported  
    Via Benzinga
    Why Integra LifeSciences Stock Is Tumbling
    Integra LifeSciences Holdings Corp (NASDAQ: IART) shares are trading lower Tuesday after the company initiated a voluntary global recall.  
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    First Republic Bank, Activision Blizzard, Enphase Energy And Other Big Stocks Moving Lower On Wednesday
    U.S. stocks traded mixed, with the Nasdaq Composite gaining over 100 points on Wednesday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Wall Street Is Bullish on GE HealthCare as It Invests in AI
    The stand-alone company that spun off from GE in January is off to a good start. 
    Via The Motley Fool
    What 6 Analyst Ratings Have To Say About Integra Lifesciences
    Via Benzinga
    Integra LifeSciences Shares Surge On Q3 Beat
    Via Benzinga
    Expert Ratings for Integra Lifesciences
    Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
    Via Benzinga
    Analyst Ratings for Integra Lifesciences
    Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings: 
    Via Benzinga
    KB Home, Bed Bath & Beyond And 3 Stocks To Watch Heading Into Wednesday
    With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
    Via Benzinga
    Integra Lifesciences's Return On Capital Employed Overview
    Pulled from Benzinga Pro data, Integra Lifesciences (NASDAQ:IART) posted Q3 earnings of $49.91 million, an increase from Q2 of 11.45%. Sales dropped to $385.19 million, a 3.17% decrease between... 
    Via Benzinga
    Integra Lifesciences: Q3 Earnings Insights
    Integra Lifesciences (NASDAQ:IART) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    4 Analysts Have This to Say About Integra Lifesciences
    Over the past 3 months, 4 analysts have published their opinion on Integra Lifesciences (NASDAQ:IART) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
    Via Benzinga
    Integra Lifesciences's Return on Invested Capital Insights
    According to Benzinga Pro, during Q2, Integra Lifesciences (NASDAQ:IART) earned $44.79 million, a 36.13% increase from the preceding quarter. Integra Lifesciences also posted a total of $397.81 million... 
    Via Benzinga
    Recap: Integra Lifesciences Q2 Earnings
      Integra Lifesciences (NASDAQ:IART) reported its Q2 earnings results on Wednesday, July 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
    Upgrades 
    Via Benzinga
    Integra LifeSciences Recalls CereLink Intracranial Pressure Monitors, Revises Guidance
    Via Benzinga
    Piper Sandler Cuts Price Target For Integra Lifesciences As It Divests Wound Care Portfolio
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022
    Upgrades 
    Via Benzinga
    Looking Into Integra Lifesciences's Return On Capital Employed
    According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million,... 
    Via Benzinga
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.